Colorectal Cancer Medicines: Generic Chemotherapy & Targeted Therapy
Colorectal cancer (CRC) affects the colon and rectum. OnlineMeds provides FDA-approved generic chemotherapy medications and targeted therapies used to treat metastatic and advanced CRC—at 88–95% savings compared to branded versions. Our portfolio includes both standard chemotherapy and modern targeted options.
Our Colorectal Cancer Treatment Options
- Capecitabine (Xeloda) — Oral 5-FU prodrug for colon and rectal cancer
- Oxaliplatin (Eloxatin) — Platinum-based chemotherapy agent
- 5-Fluorouracil (5-FU) — Classic chemotherapy backbone for CRC regimens
- Irinotecan (Camptosar) — Topoisomerase I inhibitor for advanced CRC
- Bevacizumab (Avastin) — Anti-angiogenic monoclonal antibody (special order)
- Cetuximab / Panitumumab — EGFR inhibitors (specialty sourcing available)
How These Medicines Work
CRC treatments use multiple mechanisms. Chemotherapy agents (5-FU, oxaliplatin, irinotecan) kill rapidly dividing cancer cells. Capecitabine is an oral 5-FU that activates in tumor tissue. Bevacizumab blocks blood vessel formation to starve tumors. EGFR inhibitors target growth pathways in KRAS wild-type cancers. Modern regimens combine these approaches for maximum efficacy.
Why Choose OnlineMeds for CRC Medicines?
- FDA-approved generic capecitabine, oxaliplatin, and 5-FU
- Save 88–95% on colorectal cancer chemotherapy
- Full range of first- and second-line agents
- Prescription verification and pharmacist support
- International shipping to 200+ countries
Frequently Asked Questions
Q: What is the standard treatment for metastatic colorectal cancer?
A: First-line regimens typically combine capecitabine or 5-FU + oxaliplatin (CAPOX or FOLFOX) with or without bevacizumab. Your oncologist will tailor based on your KRAS/BRAF status and fitness. This is educational information only—always follow your doctor’s plan.
Q: How often is chemotherapy given?
A: FOLFOX and CAPOX are typically given in 2-week cycles. Capecitabine is taken orally for 14 days followed by a week off. Irinotecan regimens vary. Your treatment schedule will be provided by your oncology team.
Q: What are common side effects of colorectal cancer chemotherapy?
A: Hand-foot syndrome (with capecitabine), nausea, diarrhea, low blood counts, and peripheral neuropathy (oxaliplatin) are common. Your team will manage side effects with supportive medications and dose adjustments.
Q: Can I take capecitabine and continue my normal routine?
A: Capecitabine is oral, which can make it more convenient. However, it carries significant side effects requiring monitoring. Work with your oncology team to manage fatigue and other symptoms.
Q: What if my cancer progresses on first-line chemotherapy?
A: Second-line and third-line options include irinotecan, regorafenib, and TAS-102. We can source these rapidly. Your oncologist will recommend based on your previous treatment and functional status.
Q: Are there targeted therapies for specific colorectal cancers?
A: Yes. KRAS wild-type tumors may benefit from EGFR inhibitors (cetuximab, panitumumab). Some centers test for microsatellite instability (MSI) and offer immunotherapy. Discuss molecular testing with your oncologist.
Medical Disclaimer
This content is for informational purposes only and is not intended as medical advice, diagnosis, or treatment. Colorectal cancer is a serious disease requiring specialist oncologic care. Always use CRC medicines exactly as prescribed by a licensed oncologist. If you have questions or concerns about your treatment, consult your doctor or pharmacist immediately.